1-3 of 3
Zelig Eshhar
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Allogeneic Veto-CAR CD8 T Cells Enabling Prolonged Graft Survival, Anti-Tumor Specificity, and Low Risk of Graft Versus Host Disease

Free
Wei-Hsin Liu, Anat Globerson Levin, Assaf Lask, Galit Horn, Tova Waks, Bar Nathansohn Levy, Maksim Mamonkin, Zelig Eshhar, Richard E. Champlin, Yair Reisner, Esther Bachar Lustig
Journal: Blood
Blood (2023) 142 (Supplement 1): 4833.
https://doi.org/10.1182/blood-2023-175033
Published: 2023
Journal Articles

Redirected tumor-specific allogeneic T cells for universal treatment of cancer

Free
Assaf Marcus, Tova Waks, Zelig Eshhar
Journal: Blood
Blood (2011) 118 (4): 975–983.
https://doi.org/10.1182/blood-2011-02-334284
Published: 2011
Includes: Supplemental data
Journal Articles

Redirected primary T cells harboring a chimeric receptor require costimulation for their antigen-specific activation

Free
Dinorah Friedmann-Morvinski, Alain Bendavid, Tova Waks, Daniel Schindler, Zelig Eshhar
Journal: Blood
Blood (2005) 105 (8): 3087–3093.
https://doi.org/10.1182/blood-2004-09-3737
Published: 2005